Showing results (1-10 of 48,964) with videos related to
Sort By:
Pageof 4,897
The Oncologist|July 1, 1999
The Rationale for Performing Autologous Peripheral Blood Stem Cell Transplants in Community Cancer CentersWeaver, West, Schwartzberg, et al.Bone Marrow Transplantation|November 11, 1999
High-dose chemotherapy with peripheral blood stem cell support for stage IIIB inflammatory carcinoma of the breastL Schwartzberg, C Weaver, L Lewkow, et al.Bone Marrow Transplantation|March 24, 1998
High-dose chemotherapy with BUCY or BEAC and unpurged peripheral blood stem cell infusion in patients with low-grade non-Hodgkin's lymphomaC H Weaver, L Schwartzberg, S Rhinehart, et al.Blood|November 15, 1995
An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapyC H Weaver, B Hazelton, R Birch, et al.American Journal of Clinical Oncology|April 13, 1999
Adjuvant dose-intense chemotherapy with peripheral blood stem cell support in stage II-III breast cancer with five to nine involved axillary lymph nodesL S Schwartzberg, R Birch, K W Tauer, et al.Hematology (Amsterdam, Netherlands)|July 15, 2016
The Rationale for not Routinely Purging Autologous Blood Stem Cell GraftsC D Buckner, R Birch, C H WeaverAmerican Journal of Clinical Oncology|April 13, 1999
Single-agent paclitaxel in patients with metastatic breast cancer receiving high-dose chemotherapy with peripheral blood stem cell supportL S Schwartzberg, C H Weaver, R Birch, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2000
Randomized trial of filgrastim, sargramostim, or sequential sargramostim and filgrastim after myelosuppressive chemotherapy for the harvesting of peripheral-blood stem cellsC H Weaver, K A Schulman, B Wilson-Relyea, et al.Bone Marrow Transplantation|April 1, 1997
Treatment-related mortality in 1000 consecutive patients receiving high-dose chemotherapy and peripheral blood progenitor cell transplantation in community cancer centersC H Weaver, L S Schwartzberg, J Hainsworth, et al.Bone Marrow Transplantation|November 18, 1998
A randomized trial of once vs twice daily administration of intravenous granisetron with dexamethosone in patients receiving high-dose cyclophosphamide, thiotepa and carboplatinR Birch, C H Weaver, K Carson, et al.Pageof 4,897